Despite Earning $17 Billion and Paying No Taxes from 2010 through 2012, Pfizer Seeks to Renounce American Citizenship for Tax Benefits

Founded in a red brick building in Brooklyn in 1849, Pfizer, one of America’s oldest companies and the seller of the hugely profitable Viagra and Lipitor, is seeking to renounce its American citizenship and move to climes where it can pay fewer taxes. Despite its huge success in the US with its powerhouse blockbusters bringing [...]

May 21st, 2014|Drug and Medical Device Litigation, Lipitor|Comments Off on Despite Earning $17 Billion and Paying No Taxes from 2010 through 2012, Pfizer Seeks to Renounce American Citizenship for Tax Benefits

Teva Agrees to Pay $27.6 Million to Resolve Clozapine Doctor Kickback Allegations

TEVA (Teva Pharmaceutical Industries Limited) has agreed to pay the State of Illinois and the U.S. Department of Justice $27.6 Million for violating the U.S. False Claims Act.  Units of Teva Pharmaceutical violated the Act by eliciting Dr. Michael Reinstein, an Illinois physician, to prescribe Clozapine, an anti-schizophrenia drug, to patients in federal programs such [...]

March 14th, 2014|Drug and Medical Device Litigation|Comments Off on Teva Agrees to Pay $27.6 Million to Resolve Clozapine Doctor Kickback Allegations

Lipitor Type 2 Diabetes Litigation Heating up

Countless people who took Lipitor (Atorvastatin) and were later diagnosed with type 2 diabetes are seeking to hold Pfizer and its distributors responsible.  In California, cases filed throughout the State have been coordinated before Judge Jane Johnson in Los Angeles with an initial status conference held on February 25, 2014. (See JCCP 4761). Judge Johnson [...]

March 5th, 2014|Drug and Medical Device Litigation, Lipitor|Comments Off on Lipitor Type 2 Diabetes Litigation Heating up

Pfizer’s Lipitor Faces Colluding Charges in Australia

Amid the growing lawsuits and controversy that Pfizer’s Lipitor causes type-2 diabetes in female patients between the ages of 50 and 79 with BMI (Body Mass Index) below 30, (See California coordinated Lipitor cases in Los Angeles Superior Court JCCP no. 4761; In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML)), Pfizer faces more legal [...]

February 24th, 2014|Drug and Medical Device Litigation, Lipitor|Comments Off on Pfizer’s Lipitor Faces Colluding Charges in Australia

In 2013, Lipitor, Diabetes, and Post Menopausal Women Controversy Finally Gets Attention

Thanks to all of our regular readers of The Brandi Law Firm Blog.  We try to write about matters that we are involved in representing consumers in the area of defective drugs and devices, consumer issues, and auto safety.  We have seen our readership grow by fivefold this year and we thank you for your interest. [...]

December 27th, 2013|Drug and Medical Device Litigation, Lipitor|Comments Off on In 2013, Lipitor, Diabetes, and Post Menopausal Women Controversy Finally Gets Attention

Class 1 Recall Issued by FDA Over Medtronic Faulty Cardiac Guidewires

Medtronic, Inc. initially began notifying hospitals and distributors worldwide in October 2013 that some models of its guidewires used in cardiac procedures could lose the coating on their surface resulting in the detachment and delaminating of the guidewires.  If the guidewires fail during or after the procedure, serious injury or death to the patient can [...]

November 21st, 2013|Drug and Medical Device Litigation|Comments Off on Class 1 Recall Issued by FDA Over Medtronic Faulty Cardiac Guidewires

Whistleblowers, Undercover Employees Wearing Wires Led To Johnson & Johnson’s Guilty Plea Involving Risperdal

As reported earlier, Johnson & Johnson will pay $2.2 billion due to its practices of improper marketing and failure to warn.  Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, admitted that it promoted Risperdal to health care providers for treatment of psychotic symptoms and associated behavioral disturbances exhibited by elderly, non-schizophrenic dementia patients. More facts [...]

November 12th, 2013|Drug and Medical Device Litigation|Comments Off on Whistleblowers, Undercover Employees Wearing Wires Led To Johnson & Johnson’s Guilty Plea Involving Risperdal

Lipitor and Other Statins Cause and Effect Relationship with Onset of Diabetes

Dr. Eric Topol is a cardiologist with the Scripps Clinic and a recognized pioneer in the field of cardiovascular medicine.  For fourteen years, he ran the Cleveland Health Clinic, has authored over 1100 articles and 30 books, and was a founder of the Cleveland Clinic Lerner College of Medicine. An OP Ed article he wrote [...]

August 28th, 2013|Drug and Medical Device Litigation, Lipitor|Comments Off on Lipitor and Other Statins Cause and Effect Relationship with Onset of Diabetes

Body Mass Index (BMI) Chart for Evaluation of New Onset Diabetes while taking Lipitor, Crestor, or other Statins

In January of 2012, a study published in the medical journal Archives of Internal Medicine found that female patients between the ages of 50 and 79 who took statin medications (i.e., Lipitor and other LDL-lowering drugs) were 48 percent more likely to develop type 2 diabetes as compared to women in the same age group [...]

August 8th, 2013|Drug and Medical Device Litigation, Lipitor|Comments Off on Body Mass Index (BMI) Chart for Evaluation of New Onset Diabetes while taking Lipitor, Crestor, or other Statins